German Society for Tissue Transplantation

from Wikipedia, the free encyclopedia
Logo of the DGFG

The German Society for Tissue Transplantation (DGFG) is a non-profit company with limited liability . It is the successor company of the non-profit Society for Tissue Transplantation (DSO-G), which was a wholly-owned subsidiary of the German Organ Transplantation Foundation (DSO). In 1997, the DSO commissioned her daughter to coordinate and organize the tissue donation . When the Tissue Act came into force in 2007, a spatial and legal separation was necessary. The continuation of the network under the new name DGFG was carried out by three new shareholders: the Hannover Medical School , the Carl Gustav Carus University Hospital in Dresden and the Leipzig University Hospital on August 1, 2007. In May 2015, the DGFG's group of shareholders was expanded to include the Rostock University Medical Center .

The DGFG represents a nationwide network of numerous medical institutions that are active in the field of tissue donation and transplantation . The function of the DGFG is included

  • to support tissue donation
  • to professionally support the tissue preparation in the tissue bank
  • organize the procurement of tissue transplants around the clock

The DGFG sees itself as an open network with more than ten years of experience in organizing tissue transplants. It is open to other clinics and transplant facilities from the non-profit sector and should continue to grow.

The company's headquarters have been in Hanover since 2005 . The capital of Lower Saxony was chosen for the seat because of its central location. Around 15 employees work here. Tissue donation coordinators are on duty in seven regions at university clinics and large hospitals throughout Germany.

The work of the DGFG is professionally supported by an advisory board with members from science, medicine and various health care institutions.

All generated surpluses are used directly to further promote tissue medicine. Generating a significant surplus, taking into account the legally applicable trade ban for tissue transplants, is neither possible nor desirable.

See also

Web links